• BCLC stage is acceptable, but clinical protocols must account for portal vein involvement and liver function• Treatment options for CP B/C are needed; CP B/C (ECOG PS 0 only) is an ideal population to study in advanced/metastatic HCC. Here, OPN1SW is linked to hepatocellular carcinoma.